Search

GEMVAX AS

GemVax AS was founded in 2001 by the Radium Hospital Research Foundation on the basis of more than ten years of experience in development of cancer vaccines in Norsk Hydro. The company was successfully sold to Pharmexa in 2005.

 

Name: GemVax AS
Industry: Life Science
Role: Shareholder
Status: Exit
 

Listed on the Copenhagen Stock Exchange

Tickercode: pharmx

Link:

www.pharmexa.com

 
< Previous Case

Munkedamsv. 45  Entrance A - 5th floor Vika Atrium  N-0250 Oslo Norway  Tel: +47 22 94 77 00  Fax: +47 22 94 77 01       |    Copyright©Dag Dvergsten as 2007

CorePublish publiseringsverktøy